title: A simple fluorescence based assay for quantification of human immunodeficiency virus particle release.
abstract: BACKGROUND
  The assembly and release of human immunodeficiency virus (HIV) particles from infected cells represent attractive, but not yet exploited targets for antiretroviral therapy. The availability of simple methods to measure the efficiency of these replication steps in tissue culture would facilitate the identification of host factors essential for these processes as well as the screening for lead compounds acting as specific inhibitors of particle formation. We describe here the development of a rapid cell based assay for quantification of human immunodeficiency virus type 1 (HIV-1) particle assembly and/or release.
  
  
  RESULTS
  Using a fluorescently labelled HIV-derivative, which carries an eYFP domain within the main viral structural protein Gag in the complete viral protein context, the release of virus like particles could be monitored by directly measuring the fluorescence intensity of the tissue culture supernatant. Intracellular Gag was quantitated in parallel by direct fluorescence analysis of cell lysates, allowing us to normalize for Gag expression efficiency. The assay was validated by comparison with p24 capsid ELISA measurements, a standard method for quantifying HIV-1 particles. Optimization of conditions allowed the robust detection of particle amounts corresponding to 50 ng p24/ml in medium by fluorescence spectroscopy. Further adaptation to a multi-well format rendered the assay suitable for medium or high throughput screening of siRNA libraries to identify host cell factors involved in late stages of HIV replication, as well as for random screening approaches to search for potential inhibitors of HIV-1 assembly or release.
  
  
  CONCLUSIONS
  The fast and simple fluorescence based quantification of HIV particle release yielded reproducible results which were comparable to the well established ELISA measurements, while in addition allowing the parallel determination of intracellular Gag expression. The protocols described here can be used for screening of siRNA libraries or chemical compounds, respectively, for inhibition of HIV in a 96-well format.
authors.affiliation: Department of Infectious Diseases, Virology, University Hospital Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
authors.forename: Johannes
authors.initials: J
authors.lastname: Hermle
authors.forename: Maria
authors.initials: M
authors.lastname: Anders
authors.forename: Anke-Mareil
authors.initials: AM
authors.lastname: Heuser
authors.forename: Barbara
authors.initials: B
authors.lastname: Müller
mesh_terms: D002460:Cell Line; D004797:Enzyme-Linked Immunosorbent Assay; D005453:Fluorescence; D015497:HIV-1 / Q000302:isolation & purification* / Q000502:physiology*; D006801:Humans; D034741:RNA, Small Interfering; D019065:Virus Assembly; D057074:Virus Release; D054301:gag Gene Products, Human Immunodeficiency Virus
chemical_list: D034741:RNA, Small Interfering; D054301:gag Gene Products, Human Immunodeficiency Virus
references.citation: J Virol Methods. 2007 Jul;143(1):86-94
references.pmid: 17395277
references.citation: Annu Rev Cell Dev Biol. 2004;20:395-425
references.pmid: 15473846
references.citation: Cell Host Microbe. 2008 Nov 13;4(5):495-504
references.pmid: 18976975
references.citation: Nat Struct Mol Biol. 2005 Aug;12(8):671-7
references.pmid: 16041387
references.citation: J Virol. 2004 Apr;78(7):3429-35
references.pmid: 15016865
references.citation: Nat Protoc. 2007;2(2):392-9
references.pmid: 17406600
references.citation: Biotechnol J. 2009 Jun;4(6):826-37
references.pmid: 19507150
references.citation: Science. 2008 Feb 15;319(5865):921-6
references.pmid: 18187620
references.citation: J Cell Sci. 2009 Jul 1;122(Pt 13):2163-6
references.pmid: 19535731
references.citation: J Virol. 1995 Nov;69(11):7180-6
references.pmid: 7474139
references.citation: J Biomol Screen. 2008 Aug;13(7):575-80
references.pmid: 18599879
references.citation: J Virol. 2004 Oct;78(19):10803-13
references.pmid: 15367647
references.citation: Cell Host Microbe. 2008 Dec 11;4(6):592-9
references.pmid: 19064259
references.citation: Cell. 2008 Oct 3;135(1):49-60
references.pmid: 18854154
references.citation: Nat Struct Mol Biol. 2005 Aug;12(8):678-82
references.pmid: 16041386
references.citation: Handb Exp Pharmacol. 2009;(189):321-46
references.pmid: 19048206
references.citation: J Virol. 2005 Nov;79(22):14131-40
references.pmid: 16254348
references.citation: J Biomol Screen. 1999;4(2):67-73
references.pmid: 10838414
references.citation: J Virol. 1995 Nov;69(11):6810-8
references.pmid: 7474093
references.citation: Cell. 2001 Oct 5;107(1):55-65
references.pmid: 11595185
references.citation: AIDS Rev. 2007 Jul-Sep;9(3):162-72
references.pmid: 17982941
references.citation: PLoS Pathog. 2009 May;5(5):e1000437
references.pmid: 19478882
references.citation: J Mol Biol. 2003 Apr 11;327(5):1013-20
references.pmid: 12662926
references.citation: PLoS Pathog. 2009 Nov;5(11):e1000652
references.pmid: 19893629
references.citation: J Mol Biol. 2008 May 2;378(3):565-80
references.pmid: 18374356
references.citation: Biotechnol J. 2010 Jan;5(1):39-49
references.pmid: 20013946
references.citation: Cell. 2008 Oct 31;135(3):417-20
references.pmid: 18984154
references.citation: Virology. 2007 Mar 30;360(1):92-104
references.pmid: 17097708
references.citation: AIDS Rev. 2007 Jul-Sep;9(3):150-61
references.pmid: 17982940
references.citation: J Mol Biol. 2007 Oct 19;373(2):355-66
references.pmid: 17826792
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7877-82
references.pmid: 12060735
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60
references.pmid: 14573704
references.citation: Cell Host Microbe. 2009 Jun 18;5(6):550-8
references.pmid: 19527882